Worldwide, non-infectious diseases are the leading cause of mortality and morbidity. Approximately 40 million people worldwide die each year from cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, and strokes, according to the WHO. In 2030, the International Agency for Research on Cancer (IARC) projects that 26.8 million new cases of cancer will be diagnosed and 17.1 million people will die from cancer.
Monoclonal antibodies are biological reactants that, due to their binding precision in immunodiagnostic assays, are effective against many pathogens and are therefore an important research tool. Despite the many advantages and uses that monoclonal antibodies offer, it is difficult to obtain the correct antibodies and bind a compound to them. Antibodies are time, money, and labor to produce, which can make them difficult to market. T size to some extent.
Diagnostic tests based on the use of MAb as reagents are commonly used in laboratory enzyme immunoassay and radioimmunoassay assays. These tests measure circulating hormone levels (gastrin, growth hormone, human chorionic gonadotropin, insulin, progesterone, thyroid-stimulating hormone, thyroxine, triiodothyronine, and renin) and cell products (blood clotting factors, blood group antigens, histocompatibility antigens, interferon, interleucleus antigens) and tumor hormone, intramucosal antigens.